Oncology

Prostate Cancer Screening

Detect Prostate Cancer Early with Advanced Screening Techniques

Prostate cancer screening involves testing for early signs of prostate abnormalities before symptoms appear. Using blood-based biomarkers like Prostate-Specific Antigen (PSA) and advanced molecular diagnostics, an early-stage prostate cancer screening test can identify risks—offering a greater chance for successful treatment and improved outcomes.

Conditions Detected by Prostate Cancer Screening

01
Elevated PSA levels (early indicator)
02
Prostate inflammation or benign prostatic hyperplasia (BPH)
03
Prostate adenocarcinoma
04
Aggressive or hereditary prostate cancers

Prioritize Your Prostate Health

Early Risk Identification

Detects signs of prostate cancer before symptoms develop with a reliable screening test for prostate cancer, improving long-term prognosis.

Targeted Care Planning

Enable clinicians to create personalized treatment strategies based on your diagnostic results and risk level.

Non-Invasive Testing

Quick and easy blood-based prostate cancer screening tests offer minimal discomfort with high diagnostic value.

Better Survival Rates

Early detection significantly improves treatment success and enhances long-term survival outcomes.

How It Works

Simple, Reliable, and Confidential

Blood Collection

A quick blood draw is performed to test PSA levels and relevant molecular markers.

Lab-Based Analysis

Advanced diagnostics assess PSA values and other indicators linked to prostate health.

Result Consultation

Receive a detailed clinical report with next steps, recommendations, and follow-up options.

Why Choose FSG for Prostate Screening

01

Precision Diagnostics
We use sensitive, validated assays to detect prostate-related genetic and molecular changes.

02

Expert Oversight
All results are reviewed by our oncology and molecular medicine specialists.

03

Fast Report Delivery
Get accurate results in just a few working days.

04

Trusted & Certified Lab
FSG is UAE’s first certified molecular and genomics laboratory, offering reliable prostate cancer screening services you can trust.
FAQ’s

Frequently Asked Questions!

We’re here to help. Explore answers or reach out to our team directly.
A screening test for prostate cancer is a medical procedure used to check for early signs of the disease before symptoms appear. The most common method is a PSA (Prostate-Specific Antigen) blood test, which measures PSA levels in the blood. If the levels are elevated, further evaluation may be recommended to determine the cause.
Prostate cancer screening typically involves a simple blood draw to test PSA levels, along with optional molecular analysis to detect specific markers linked to prostate conditions. This approach helps identify individuals at risk, even if they are not showing symptoms, allowing for early medical intervention if needed.
Most men should begin discussing prostate cancer screening tests with their doctor around age 50. However, those with a family history of cancer may be advised to start screening earlier, often between ages 40 and 45.
While the PSA test is a valuable tool, it is not always conclusive. For more accurate results, a screening test for prostate cancer may be combined with advanced diagnostics such as molecular profiling or follow-up imaging. This helps differentiate between benign conditions and more serious concerns.
Prostate cancer screening helps detect cancer at an early stage, when it is most treatable. Regular testing improves the chances of identifying slow-growing or aggressive cancers early, enabling better treatment planning and potentially reducing long-term health risks.

Ready to Get Started? Schedule Your Appointment

    Are You Ready? Book Appointment Now!